X-153905541-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000054.7(AVPR2):​c.35G>A​(p.Gly12Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0238 in 1,190,008 control chromosomes in the GnomAD database, including 371 homozygotes. There are 9,504 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. G12G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.024 ( 38 hom., 858 hem., cov: 26)
Exomes 𝑓: 0.024 ( 333 hom. 8646 hem. )

Consequence

AVPR2
NM_000054.7 missense

Scores

16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 1.11

Publications

13 publications found
Variant links:
Genes affected
AVPR2 (HGNC:897): (arginine vasopressin receptor 2) This gene encodes the vasopressin receptor, type 2, also known as the V2 receptor, which belongs to the seven-transmembrane-domain G protein-coupled receptor (GPCR) superfamily, and couples to Gs thus stimulating adenylate cyclase. The subfamily that includes the V2 receptor, the V1a and V1b vasopressin receptors, the oxytocin receptor, and isotocin and mesotocin receptors in non-mammals, is well conserved, though several members signal via other G proteins. All bind similar cyclic nonapeptide hormones. The V2 receptor is expressed in the kidney tubule, predominantly in the distal convoluted tubule and collecting ducts, where its primary property is to respond to the pituitary hormone arginine vasopressin (AVP) by stimulating mechanisms that concentrate the urine and maintain water homeostasis in the organism. When the function of this gene is lost, the disease Nephrogenic Diabetes Insipidus (NDI) results. The V2 receptor is also expressed outside the kidney although its tissue localization is uncertain. When these 'extrarenal receptors' are stimulated by infusion of a V2 selective agonist (dDAVP), a variety of clotting factors are released into the bloodstream. The physiologic importance of this property is not known - its absence does not appear to be detrimental in NDI patients. The gene expression has also been described in fetal lung tissue and lung cancer associated with alternative splicing. [provided by RefSeq, Jul 2008]
AVPR2 Gene-Disease associations (from GenCC):
  • diabetes insipidus, nephrogenic, X-linked
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • nephrogenic syndrome of inappropriate antidiuresis
    Inheritance: XL Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • nephrogenic diabetes insipidus
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0018711984).
BP6
Variant X-153905541-G-A is Benign according to our data. Variant chrX-153905541-G-A is described in ClinVar as [Benign]. Clinvar id is 254773.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0844 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AVPR2NM_000054.7 linkc.35G>A p.Gly12Glu missense_variant Exon 3 of 4 ENST00000646375.2 NP_000045.1 P30518-1
AVPR2NM_001146151.3 linkc.35G>A p.Gly12Glu missense_variant Exon 3 of 3 NP_001139623.1 P30518-2
AVPR2NR_027419.2 linkn.465+371G>A intron_variant Intron 2 of 3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AVPR2ENST00000646375.2 linkc.35G>A p.Gly12Glu missense_variant Exon 3 of 4 NM_000054.7 ENSP00000496396.1 P30518-1
ENSG00000284987ENST00000646191.1 linkn.96+3529C>T intron_variant Intron 1 of 4 ENSP00000493873.1 A0A2R8Y4P6

Frequencies

GnomAD3 genomes
AF:
0.0242
AC:
2726
AN:
112534
Hom.:
39
Cov.:
26
show subpopulations
Gnomad AFR
AF:
0.0225
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0504
Gnomad ASJ
AF:
0.0169
Gnomad EAS
AF:
0.0276
Gnomad SAS
AF:
0.0541
Gnomad FIN
AF:
0.0203
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.0191
Gnomad OTH
AF:
0.0276
GnomAD2 exomes
AF:
0.0381
AC:
5264
AN:
138128
AF XY:
0.0377
show subpopulations
Gnomad AFR exome
AF:
0.0215
Gnomad AMR exome
AF:
0.0965
Gnomad ASJ exome
AF:
0.0175
Gnomad EAS exome
AF:
0.0294
Gnomad FIN exome
AF:
0.0211
Gnomad NFE exome
AF:
0.0185
Gnomad OTH exome
AF:
0.0393
GnomAD4 exome
AF:
0.0238
AC:
25601
AN:
1077422
Hom.:
333
Cov.:
35
AF XY:
0.0246
AC XY:
8646
AN XY:
351270
show subpopulations
African (AFR)
AF:
0.0213
AC:
551
AN:
25861
American (AMR)
AF:
0.0871
AC:
2834
AN:
32537
Ashkenazi Jewish (ASJ)
AF:
0.0173
AC:
328
AN:
18989
East Asian (EAS)
AF:
0.0443
AC:
1280
AN:
28917
South Asian (SAS)
AF:
0.0583
AC:
3032
AN:
51972
European-Finnish (FIN)
AF:
0.0200
AC:
764
AN:
38283
Middle Eastern (MID)
AF:
0.0643
AC:
232
AN:
3609
European-Non Finnish (NFE)
AF:
0.0187
AC:
15541
AN:
832052
Other (OTH)
AF:
0.0230
AC:
1039
AN:
45202
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
1022
2044
3065
4087
5109
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
642
1284
1926
2568
3210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0242
AC:
2723
AN:
112586
Hom.:
38
Cov.:
26
AF XY:
0.0247
AC XY:
858
AN XY:
34780
show subpopulations
African (AFR)
AF:
0.0225
AC:
698
AN:
31084
American (AMR)
AF:
0.0501
AC:
541
AN:
10790
Ashkenazi Jewish (ASJ)
AF:
0.0169
AC:
45
AN:
2657
East Asian (EAS)
AF:
0.0274
AC:
97
AN:
3541
South Asian (SAS)
AF:
0.0553
AC:
152
AN:
2747
European-Finnish (FIN)
AF:
0.0203
AC:
126
AN:
6221
Middle Eastern (MID)
AF:
0.0324
AC:
7
AN:
216
European-Non Finnish (NFE)
AF:
0.0191
AC:
1015
AN:
53108
Other (OTH)
AF:
0.0272
AC:
42
AN:
1542
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
100
200
300
400
500
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0216
Hom.:
252
Bravo
AF:
0.0266
TwinsUK
AF:
0.0146
AC:
54
ALSPAC
AF:
0.0145
AC:
42
ESP6500AA
AF:
0.0226
AC:
81
ESP6500EA
AF:
0.0167
AC:
107
ExAC
AF:
0.0311
AC:
3667

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 18, 2020
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:4
May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 10526945, 27884173, 20403097, 9027323, 7987330, 22995991, 22644838) -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Diabetes insipidus, nephrogenic, X-linked Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.099
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
6.7
DANN
Benign
0.68
DEOGEN2
Benign
0.40
T;T;.;T;.
FATHMM_MKL
Benign
0.071
N
LIST_S2
Benign
0.71
.;.;T;T;T
MetaRNN
Benign
0.0019
T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.1
L;L;.;L;L
PhyloP100
1.1
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-0.45
.;N;N;N;N
REVEL
Benign
0.048
Sift
Benign
0.72
.;T;D;T;T
Sift4G
Benign
0.62
.;T;T;T;T
Polyphen
0.0040
B;B;.;B;B
Vest4
0.037, 0.039, 0.038
MPC
0.71
ClinPred
0.0029
T
GERP RS
0.23
PromoterAI
-0.014
Neutral
Varity_R
0.057
gMVP
0.73
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.11
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2071126; hg19: chrX-153170995; COSMIC: COSV61685746; COSMIC: COSV61685746; API